Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Cash from Investing Activities (2022 - 2025)

CervoMed's Cash from Investing Activities history spans 6 years, with the latest figure at $7.6 million for Q3 2025.

  • For Q3 2025, Cash from Investing Activities rose 191.34% year-over-year to $7.6 million; the TTM value through Sep 2025 reached $22.0 million, up 158.02%, while the annual FY2024 figure was -$28.7 million, N/A changed from the prior year.
  • Cash from Investing Activities for Q3 2025 was $7.6 million at CervoMed, up from -$254993.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $9.5 million in Q1 2023 and bottomed at -$40.6 million in Q2 2024.
  • The 4-year median for Cash from Investing Activities is $3.0 million (2022), against an average of -$2.3 million.
  • The largest annual shift saw Cash from Investing Activities plummeted 9544.28% in 2023 before it soared 191.34% in 2025.
  • A 4-year view of Cash from Investing Activities shows it stood at $7.0 million in 2022, then plummeted by 235.71% to -$9.5 million in 2023, then soared by 197.97% to $9.3 million in 2024, then decreased by 18.53% to $7.6 million in 2025.
  • Per Business Quant, the three most recent readings for CRVO's Cash from Investing Activities are $7.6 million (Q3 2025), -$254993.0 (Q2 2025), and $5.4 million (Q1 2025).